Targeting PIKfyve-driven lipid metabolism in pancreatic cancerCaleb Cheng, Arul M. Chinnaiyan, Lanbo Xiao et al.|Nature|2025Cited by 37
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancerTongchen He, Arul M. Chinnaiyan, Caleb Cheng et al.|Proceedings of the National Academy of Sciences|2024Cited by 22
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Arul M. Chinnaiyan, Jing Hu et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 5
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancerTongchen He, Arul M. Chinnaiyan, Caleb Cheng et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 4
Abstract 1634: Novel autophagy inhibitor ESK981 potentiates MEK inhibition cytotoxicity in pancreatic cancerCaleb Cheng, Arul M. Chinnaiyan, Jasmine P. Wisniewski et al.|Cancer Research|2023Cited by 0